These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 2860990

  • 1. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Concomitant therapy with labetalol and hydrochlorothiazide in moderate to moderately severe essential hypertension.
    Kochar MS, Tyson J, Kalbfleisch JH.
    J Clin Pharmacol; 1985 Sep; 25(6):433-6. PubMed ID: 3902912
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME, Moir GD, Poland MP, Maloy J, Medakovic M.
    Am J Med; 1983 Oct 17; 75(4A):47-53. PubMed ID: 6356899
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA, Glasser SP, Ram CV, McMahon SG, Vanov SK, Leibowitz DA.
    J Cardiovasc Pharmacol; 1984 Oct 17; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [Abstract] [Full Text] [Related]

  • 10. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
    Michelson EL, Frishman WH, Lewis JE, Edwards WT, Flanigan WJ, Bloomfield SS, Johnson BF, Lucas C, Freis ED, Finnerty FA.
    Am J Med; 1983 Oct 17; 75(4A):68-80. PubMed ID: 6356901
    [Abstract] [Full Text] [Related]

  • 11. Labetalol in the treatment of essential hypertension: a single-blind dose ranging study.
    Dux S, Grosskopf I, Boner G, Rosenfeld JB.
    J Clin Pharmacol; 1986 Oct 17; 26(5):346-50. PubMed ID: 3700690
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive efficacy and tolerability of captopril in the elderly: comparison with hydrochlorothiazide and placebo in a multicentre, double-blind study.
    Muiesan G, Agabiti-Rosei E, Buoninconti R, Cagli V, Carotti A, Corea L, Innocenti P, Malerba M, Paciaroni E, Pirrelli A.
    J Hypertens Suppl; 1987 Dec 17; 5(5):S599-602. PubMed ID: 3327931
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP, Durier P, Bussiere JL, Gayet JL.
    Eur J Clin Pharmacol; 1990 Dec 17; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [Abstract] [Full Text] [Related]

  • 14. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 17; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 15. The results of a large multicentre study comparing low-dose lisinopril-hydrochlorothiazide with the monocomponents.
    Lang H.
    J Hum Hypertens; 1991 Dec 17; 5 Suppl 2():73-6. PubMed ID: 1665182
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 17; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 17. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
    Gonzalez ER, Peterson MA, Racht EM, Ornato JP, Due DL.
    Ann Emerg Med; 1991 Apr 17; 20(4):333-8. PubMed ID: 2003657
    [Abstract] [Full Text] [Related]

  • 18. Tiapamil and hydrochlorothiazide: a double-blind comparison of two antihypertensive agents.
    Storm TL, Badskjaer J, Hammer R, Kögler P.
    J Clin Pharmacol; 1987 Jan 17; 27(1):18-21. PubMed ID: 3316301
    [Abstract] [Full Text] [Related]

  • 19. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.
    Pool PE, Applegate WB, Woehler T, Sandall P, Cady WJ.
    Pharmacotherapy; 1993 Jan 17; 13(5):487-93. PubMed ID: 8247917
    [Abstract] [Full Text] [Related]

  • 20. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ, Nassim M, Armstrong BK, Beilin L.
    Br J Clin Pharmacol; 1979 Jan 17; 7(1):63-8. PubMed ID: 367410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.